Zika virus is transmitted through Aedes mosquito bite, which can also transmit chikungunya, dengue, and yellow fever. The other modes of transmission of Zika virus is through sex and from an infected mother to the fetus. The onset of Zika virus is yet not clear. The symptoms are similar to that of dengue, including fever, skin rashes, joint pain, and headache, which are mild and last for two to seven days.

The Zika virus vaccines market is estimated to generate $14,500 million in 2017, and is expected to reach $18,697 million by 2022, growing at a CAGR of 5.2%. The market has high potential owing to increase in demand for vaccines for immunization and further prevention in regions such as Latin America and Central America. According to WHO, approximately 1.6 million individuals are infected with Zika virus, and the number is exponentially increasing. In addition, surgical demand for vaccines that can cure Zika-linked birth defects has increased.

Check complete report @ http://www.marketintelreports.com/report/allied0625/zika-virus-vaccines-market-by-forecast-scenario-analysis-rapid-growth-scenario-moderate-growth-scenario-and-low-growth-scenario--global-opportunity-analysis-and-industry-forecast-20172022
Zika virus disease is caused by mosquitoes that belongs to Flavivirus genus, and was first identified in Uganda in 1947 in monkeys. It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania. Major outbreak of the disease was reported in 2007 in the Yap Island. In addition, an association between Zika virus infection and Guillain–Barré syndrome was reported in July 2015 in Brazil, and later in October 2015, Brazil reported an association between Zika virus infection and microcephaly.

Avail more information from Sample Brochure of report @ http://www.marketintelreports.com/pdfdownload.php?id=allied0625

KEYMARKET BENEFITS:
In-depth study of the global Zika virus vaccines market was conducted based on the current disease prevalence, target population, and pricing to generate market size & forecast from 2017 to 2022.
Potential analysis of opportunities was evaluated to understand different aspects of Zika virus vaccines that are currently clinical trials along with the variants that are expected to gain prominence in the future.
Key market players are profiled and their strategies are analyzed thoroughly to understand the various technologies adopted by them to manufacture Zika virus vaccines.

Order a copy of Global Market Research Report http://www.marketintelreports.com/purchase.php?id=allied0625

About us:
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Contact us:
Vikas
2711 Centerville Road, Suite 400,
Wilmington,Delaware,19808
United States
www.marketintelreports.com
[email protected]
Telephone: 1-302-261-5343